Clinical trial

Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis

NCT00641225

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-31

PhasePHASE1

Study timeline

Study start (actual)2008-03-31Date precision: day

Registry last updated2023-09-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

SBI-087DRUG

Sponsors & collaborators

Pfizerlead sponsor

Emergent Product Development Seattle LLCcollaborator

Mapped research locations

DallasTexas, United States1 MiamiFlorida, United States1 TorontoOntario, Canada1 MontrealQuebec, Canada1 DurhamNorth Carolina, United States1 EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00641225 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.